Harbor Capital Advisors Inc. Has $1.37 Million Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Harbor Capital Advisors Inc. increased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 113.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 16,188 shares of the company's stock after buying an additional 8,604 shares during the quarter. Harbor Capital Advisors Inc. owned 0.11% of U.S. Physical Therapy worth $1,370,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in USPH. Silvercrest Asset Management Group LLC bought a new position in U.S. Physical Therapy during the 1st quarter worth about $8,158,000. Vanguard Group Inc. increased its holdings in U.S. Physical Therapy by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company's stock worth $121,065,000 after purchasing an additional 10,175 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in U.S. Physical Therapy by 5.8% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 12,642 shares of the company's stock worth $1,423,000 after purchasing an additional 696 shares in the last quarter. First Horizon Advisors Inc. increased its holdings in U.S. Physical Therapy by 18.6% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company's stock worth $110,000 after purchasing an additional 186 shares in the last quarter. Finally, Advisors Asset Management Inc. increased its holdings in U.S. Physical Therapy by 78.4% during the 1st quarter. Advisors Asset Management Inc. now owns 1,056 shares of the company's stock worth $119,000 after purchasing an additional 464 shares in the last quarter.

U.S. Physical Therapy Stock Up 17.7 %

Shares of NYSE USPH traded up $14.57 during mid-day trading on Wednesday, hitting $97.10. The company had a trading volume of 267,762 shares, compared to its average volume of 91,248. The company has a market capitalization of $1.46 billion, a PE ratio of 77.83, a price-to-earnings-growth ratio of 3.93 and a beta of 1.38. The firm has a 50-day simple moving average of $82.93 and a two-hundred day simple moving average of $91.49. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.68 by $0.01. The company had revenue of $168.03 million during the quarter, compared to analysts' expectations of $163.97 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. On average, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.58 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be paid a $0.44 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.76 annualized dividend and a yield of 1.81%. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 166.04%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on USPH shares. Bank of America reiterated a "neutral" rating and set a $90.00 target price (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Barrington Research restated an "outperform" rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a report on Wednesday, October 9th. Finally, StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Wednesday, August 21st.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of the firm's stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at approximately $580,635. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, Director Kathleen A. Gilmartin acquired 2,000 shares of the business's stock in a transaction on Tuesday, September 3rd. The stock was purchased at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the transaction, the director now directly owns 18,904 shares of the company's stock, valued at approximately $1,627,445.36. The trade was a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Graham D. Reeve sold 1,724 shares of the firm's stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares of the company's stock, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by company insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.